CTLA-4 checkpoint inhibitor (MI Bioresearch)

N/A

Report date: 2025/03/18 18:12:44

Base Information

Drug NameCTLA-4 checkpoint inhibitor (MI Bioresearch)
Drug Alias Nameanti-CTLA-4 antibody (MI Bioresearch)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionCytotoxic T-Lymphocyte-Associated Antigen 4 inhibitors
TargetsCytotoxic T-Lymphocyte-Associated Antigen 4
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMI Bioresearch
China Registration ClassN/A

Develop Information

Active CompaniesMI Bioresearch
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A